Consistent with this, LCN2 was found to be a component of the key signature in the onset of endometrial cancer in the glandular uterine epithelium, as its expression increased in precancerous atypical endometrial hyperplasia (88). The gene discussed is LCN2; the disease is endometrial cancer.